304 related articles for article (PubMed ID: 31858807)
1. Bioengineering Bacterial Vesicle-Coated Polymeric Nanomedicine for Enhanced Cancer Immunotherapy and Metastasis Prevention.
Chen Q; Bai H; Wu W; Huang G; Li Y; Wu M; Tang G; Ping Y
Nano Lett; 2020 Jan; 20(1):11-21. PubMed ID: 31858807
[TBL] [Abstract][Full Text] [Related]
2. Surface-Layer Protein-Enhanced Immunotherapy Based on Cell Membrane-Coated Nanoparticles for the Effective Inhibition of Tumor Growth and Metastasis.
Wu M; Liu X; Bai H; Lai L; Chen Q; Huang G; Liu B; Tang G
ACS Appl Mater Interfaces; 2019 Mar; 11(10):9850-9859. PubMed ID: 30788951
[TBL] [Abstract][Full Text] [Related]
3. Bacterial outer membrane vesicles-based therapeutic platform eradicates triple-negative breast tumor by combinational photodynamic/chemo-/immunotherapy.
Li Y; Wu J; Qiu X; Dong S; He J; Liu J; Xu W; Huang S; Hu X; Xiang DX
Bioact Mater; 2023 Feb; 20():548-560. PubMed ID: 35846843
[TBL] [Abstract][Full Text] [Related]
4. A novel cancer immunotherapy based on the combination of a synthetic carbohydrate-pulsed dendritic cell vaccine and glycoengineered cancer cells.
Qiu L; Li J; Yu S; Wang Q; Li Y; Hu Z; Wu Q; Guo Z; Zhang J
Oncotarget; 2015 Mar; 6(7):5195-203. PubMed ID: 25760071
[TBL] [Abstract][Full Text] [Related]
5. Exploiting in situ antigen generation and immune modulation to enhance chemotherapy response in advanced melanoma: A combination nanomedicine approach.
Lu Y; Wang Y; Miao L; Haynes M; Xiang G; Huang L
Cancer Lett; 2016 Aug; 379(1):32-8. PubMed ID: 27235608
[TBL] [Abstract][Full Text] [Related]
6. Bioinspired and Biomimetic Nanomedicines.
Chen Z; Wang Z; Gu Z
Acc Chem Res; 2019 May; 52(5):1255-1264. PubMed ID: 30977635
[TBL] [Abstract][Full Text] [Related]
7. A Self-Delivery Chimeric Peptide for Photodynamic Therapy Amplified Immunotherapy.
Cheng H; Fan GL; Fan JH; Zheng RR; Zhao LP; Yuan P; Zhao XY; Yu XY; Li SY
Macromol Biosci; 2019 Apr; 19(4):e1800410. PubMed ID: 30576082
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine.
Shi GN; Zhang CN; Xu R; Niu JF; Song HJ; Zhang XY; Wang WW; Wang YM; Li C; Wei XQ; Kong DL
Biomaterials; 2017 Jan; 113():191-202. PubMed ID: 27816821
[TBL] [Abstract][Full Text] [Related]
9. Human xenograft-nude mouse model of adoptive immunotherapy with human melanoma-specific cytotoxic T-cells.
Crowley NJ; Vervaert CE; Seigler HF
Cancer Res; 1992 Jan; 52(2):394-9. PubMed ID: 1728411
[TBL] [Abstract][Full Text] [Related]
10. Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response.
Liang R; Xie J; Li J; Wang K; Liu L; Gao Y; Hussain M; Shen G; Zhu J; Tao J
Biomaterials; 2017 Dec; 149():41-50. PubMed ID: 28992509
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice.
Okada N; Masunaga Y; Okada Y; Mizuguchi H; Iiyama S; Mori N; Sasaki A; Nakagawa S; Mayumi T; Hayakawa T; Fujita T; Yamamoto A
Gene Ther; 2003 Oct; 10(22):1891-902. PubMed ID: 14502218
[TBL] [Abstract][Full Text] [Related]
12. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
[TBL] [Abstract][Full Text] [Related]
13. Enhanced chemo-immunotherapy against melanoma by inhibition of cholesterol esterification in CD8
Li M; Yang Y; Wei J; Cun X; Lu Z; Qiu Y; Zhang Z; He Q
Nanomedicine; 2018 Nov; 14(8):2541-2550. PubMed ID: 30193815
[TBL] [Abstract][Full Text] [Related]
14. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.
Kaplan JM; Yu Q; Piraino ST; Pennington SE; Shankara S; Woodworth LA; Roberts BL
J Immunol; 1999 Jul; 163(2):699-707. PubMed ID: 10395660
[TBL] [Abstract][Full Text] [Related]
15. Genetic vaccination against the melanocyte lineage-specific antigen gp100 induces cytotoxic T lymphocyte-mediated tumor protection.
Schreurs MW; de Boer AJ; Figdor CG; Adema GJ
Cancer Res; 1998 Jun; 58(12):2509-14. PubMed ID: 9635569
[TBL] [Abstract][Full Text] [Related]
16. Surgical Tumor-Derived Personalized Photothermal Vaccine Formulation for Cancer Immunotherapy.
Ye X; Liang X; Chen Q; Miao Q; Chen X; Zhang X; Mei L
ACS Nano; 2019 Mar; 13(3):2956-2968. PubMed ID: 30789699
[TBL] [Abstract][Full Text] [Related]
17. Modified bacterial outer membrane vesicles induce autoantibodies for tumor therapy.
Huang W; Shu C; Hua L; Zhao Y; Xie H; Qi J; Gao F; Gao R; Chen Y; Zhang Q; Li W; Yuan M; Ye C; Ma Y
Acta Biomater; 2020 May; 108():300-312. PubMed ID: 32251780
[TBL] [Abstract][Full Text] [Related]
18. Restoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation.
Li SY; Liu Y; Xu CF; Shen S; Sun R; Du XJ; Xia JX; Zhu YH; Wang J
J Control Release; 2016 Jun; 231():17-28. PubMed ID: 26829099
[TBL] [Abstract][Full Text] [Related]
19. Nanomedicine-Based Immunotherapy for the Treatment of Cancer Metastasis.
Zhang P; Zhai Y; Cai Y; Zhao Y; Li Y
Adv Mater; 2019 Dec; 31(49):e1904156. PubMed ID: 31566275
[TBL] [Abstract][Full Text] [Related]
20. Development of Multifunctional Clay-Based Nanomedicine for Elimination of Primary Invasive Breast Cancer and Prevention of Its Lung Metastasis and Distant Inoculation.
Zhang LX; Sun XM; Xu ZP; Liu RT
ACS Appl Mater Interfaces; 2019 Oct; 11(39):35566-35576. PubMed ID: 31496214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
